Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2126 stock hub

HKG/2126 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2126is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2126

In the news

Latest news · HKG/2126

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-64.4

P25 -14.7P50 2P75 9.4

ROIC-12.6

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2126 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

CNY

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	314
Employees Change	33%
Employees Change Percent	11.74
Enterprise value	HKD 811.2M
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG5210T1040
Last refreshed	2026-05-10
Market cap	HKD 1.1B
Price	HKD 2.66
Price currency	HKD
Rev Per Employee	1,005,261.04x
Sector	Healthcare
Sic	2836
Symbol	hkg/2126
Website	https://www.jwtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-57.27%
EV Earnings	-1.31x
EV/FCF	-9.32x
EV/Sales	2.57x
FCF yield	-8.07%
P/B ratio	1.74x
P/S ratio	3.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-85.98%
EBITDA Margin	-63.9%
Gross margin	61.02%
Gross Profit	HKD 192.6M
Gross Profit Growth	75.38%
Gross Profit Growth Q	221.6%
Gross Profit Growth3 Y	25.7%
Gross Profit Growth5 Y	16.56%
Net Income	HKD -617.9M
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Pretax Margin	-194.68%
Profit Margin	-195.76%
Profit Per Employee	HKD -2M
ROA	-11.43
Roa5y	-13.92
ROCE	-41.16
ROE	-64.37
Roe5y	-39.86
ROIC	-12.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	82.27%
Cagr3y	-8.48%
Cagr5y	-38.1%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth	79.28x
Revenue Growth Q	148.32x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	17.93x
Revenue Growth5 Y	11.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.21
Assets	HKD 1.1B
Cash	HKD 560M
Current Assets	HKD 656.7M
Current Liabilities	HKD 454.2M
Debt	HKD 292.2M
Debt Equity	HKD 0.47
Debt FCF	HKD -3.36
Equity	HKD 619M
Interest Coverage	-21.33
Liabilities	HKD 479.2M
Long Term Assets	HKD 441.5M
Long Term Liabilities	HKD 25M
Net Cash	HKD 267.8M
Net Cash By Market Cap	HKD 24.82
Net Cash Growth	-29.24%
Net Debt Equity	HKD -0.43
Tangible Book Value	HKD 405.9M
Tangible Book Value Per Share	HKD 1
WACC	12.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.45
Inventory Turnover	2.37
Net Working Capital	HKD -112.4M
Quick ratio	1.28
Working Capital	HKD 195.8M
Working Capital Turnover	HKD 1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	82.19%
200-day SMA	3.37
3Y total return	-23.34%
50-day SMA	2.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.91%
All Time High	52.8
All Time High Change	-94.96%
All Time High Date	2021-02-22
All Time Low	1.19
All Time Low Change	123.53%
All Time Low Date	2024-09-11
ATR	0.16
Beta	1.91
Beta1y	1.34
Beta2y	1
Ch YTD	5.98
High	2.72
High52	6.44
High52 Date	2025-07-30
High52ch	-58.7%
Low	2.62
Low52	1.43
Low52 Date	2025-05-08
Low52ch	86.01%
Ma50ch	22.92%
Price vs 200-day SMA	-21%
RSI	64.08
RSI Monthly	46.46
RSI Weekly	50.62
Sharpe ratio	1.01x
Sortino ratio	1.92
Total Return	-0.52%
Tr YTD	5.98
Tr1m	21.46%
Tr1w	15.65%
Tr3m	19.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -271.4M
Operating margin	-85.98

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	320,436,959%
Net Borrowing	-182,493,954.6
Shares Insiders	3.69%
Shares Institutions	0.85%
Shares Out	405,639,141
Shares Qo Q	0.07%
Shares Yo Y	0.52%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -92M
Average Volume	1,233,975x
Bv Per Share	1.53
CAPEX	HKD -1.5M
Ch1m	21.46
Ch1w	15.65
Ch1y	82.19
Ch3m	19.28
Ch3y	-23.34
Ch5y	-90.91
Ch6m	-22.45
Change	-2.21%
Change From Open	-1.85
Close	2.72
Days Gap	-0.37
Depreciation Amortization	72,102,817.3
Dollar Volume	3,277,120
Earnings Date	2026-05-27
EBIT	HKD -271.4M
EBITDA	HKD -201.7M
EPS	HKD -1.49
F Score	4
FCF	HKD -87.1M
FCF EV Yield	-10.73x
FCF Per Share	HKD -0.21
Financing CF	-188,971,872
Fiscal Year End	December
Founded	2,016
Income Tax	HKD 3.4M
Investing CF	-1,655,862
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	2.82
Ma150ch	-5.67%
Ma20	2.41
Ma20ch	10.19%
Net CF	-282,997,661
Next Earnings Date	2026-05-27
Open	2.71
Position In Range	40
Ppne	242,439,720.8
Price Date	2026-05-08
Ptbv Ratio	2.66
Relative Volume	1x
Revenue	315,651,965x
SBC By Revenue	1.57x
Share Based Comp	4,946,442
Tax By Revenue	1.08x
Tr6m	-22.45%
Volume	1,232,000
Z Score	-7.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2126 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2126 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2126?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.9%

Share of float held by funds and institutions

Insider ownership

+3.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

HKG/2126 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.1

Neutral momentum band

Price vs 200-day MA

-21.0%

50/200-day relationship not available

Beta (5Y)

1.91

More volatile than the market

Sharpe ratio

1.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2126

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2126 stock rating?

hkg/2126 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2126 analysis?

The full report lives at /stocks/hkg/2126/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2126?

The latest report frames hkg/2126 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2126 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.